No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ABOS Acumen Pharmaceuticals
- 3.215
- +0.055+1.74%
Trading Apr 19 09:45 ET
193.16MMarket Cap-2976P/E (TTM)
3.300High3.170Low39.34KVolume3.240Open3.160Pre Close127.13KTurnover0.12%Turnover RatioLossP/E (Static)60.08MShares11.31052wk High0.72P/B103.78MFloat Cap1.81052wk Low--Dividend TTM32.28MShs Float26.980Historical High--Div YieldTTM4.11%Amplitude1.810Historical Low3.231Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Watching Eledon Pharmaceuticals, Acumen Pharmaceuticals; Shares See Volume On TipRanks Article Titled "These 2 'Strong Buy' Penny Stocks Are Poised for Over 300% Gains, Say Analysts"
Acumen Pharmaceuticals Presents First Comprehensive Clinical And Biomarker Data For Sabirnetug At American Academy Of Neurology 2024 Annual Meeting
Presentation and poster include deeper data insights on sabirnetug safety profile, target engagement and fluid biomarker changesPresentation to be featured during AAN Emerging Science SessionCompany o
13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
Lonza Enters Manufacturing Agreement for Acumen's Alzheimer's Disease Drug Candidate
Lonza Group (LONN.SW) and Acumen Pharmaceuticals signed a clinical development and commercialization deal for the latter's sabirnetug drug candidate, which is being studied for the treatment of Alzhei
Express News | Acumen Pharmaceuticals Collaborates With Lonza Covering The Manufacture Of Sabirnetug (ACU193) For Alzheimer's Disease, For Clinical Development And Commercialization, If Approved
Analysts Offer Insights on Healthcare Companies: LAVA Therapeutics (LVTX), Acumen Pharmaceuticals (ABOS) and Advanced Medical Solutions (GB:AMS)
Comments
$Acumen Pharmaceuticals(ABOS.US$
NEWS
Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting
Sabirnetug demonstrated a favorable safety profile with low incidence of ARIA-E in early AD participants.
Target engagement with AβOs in cerebrospinal fluid increased in a dose-dependent manner, suggesting active removal of target from the brain.
Sabirnetug treatment led to changes in CSF and plasma bio...
NEWS
Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting
Sabirnetug demonstrated a favorable safety profile with low incidence of ARIA-E in early AD participants.
Target engagement with AβOs in cerebrospinal fluid increased in a dose-dependent manner, suggesting active removal of target from the brain.
Sabirnetug treatment led to changes in CSF and plasma bio...
Getting ducks in a row just in case! LIKE the optimism
$Acumen Pharmaceuticals(ABOS.US$ Acumen Pharmaceuticals Collaborates With Lonza Covering The Manufacture Of Sabirnetug (ACU193) For Alzheimer's Disease, For Clinical Development And Commercialization, If Approved
1
$Acumen Pharmaceuticals(ABOS.US$
slowly moving up
slowly moving up
2
Hmm! A bit more I can add to my liking!
$Acumen Pharmaceuticals(ABOS.US$ announced that it has entered into a senior secured loan and security agreement with K2 HealthVentures, a healthcare-focused specialty finance company.
2
Longer term swing/But could be DT?
$Acumen Pharmaceuticals(ABOS.US$ Just off ATL ( you know how i likes me some bottom bouncers, hehehe ) Earnings out Monday 11/13/23 BMO! But mainly for the following! Phase 1 data on ACU193/INTERCEPT-AD was very promising! The Recent collaboration & License agreement with HALOZYME Could make this Alzheimer’s treatment a game changer for patients by allowing the delivery of the drug Subcutaneously instead of IV? Which would be much more convenient and less inva...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg